The acute anti-craving effect of acamprosate in alcohol-preferring rats is associated with modulation of the mesolimbic dopamine system. - Wikidata - wikimedia - TriplyDB

The acute anti-craving effect of acamprosate in alcohol-preferring rats is associated with modulation of the mesolimbic dopamine system.

The acute anti-craving effect of acamprosate in alcohol-preferring rats is associated with modulation of the mesolimbic dopamine system.

http://www.wikidata.org/entity/Q46658074

about

The orexin system regulates alcohol-seeking in rats The development of acamprosate as a treatment against alcohol relapse High temporal resolution of amino acid levels in rat nucleus accumbens during operant ethanol self-administration: involvement of elevated glycine in anticipation.Evidence for the role of dopamine D3 receptors in oral operant alcohol self-administration and reinstatement of alcohol-seeking behavior in mice Acamprosate produces its anti-relapse effects via calcium Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity Cue-conditioned alcohol seeking in rats following abstinence: involvement of metabotropic glutamate 5 receptors.Acamprosate and naltrexone treatment effects on ethanol and sucrose seeking and intake in ethanol-dependent and nondependent rats Brucine suppresses ethanol intake and preference in alcohol-preferring Fawn-Hooded rats.Assessing ethanol's actions in the suprachiasmatic circadian clock using in vivo and in vitro approaches.Discrete cue-conditioned alcohol-seeking after protracted abstinence: pattern of neural activation and involvement of orexin₁ receptors.Acamprosate-responsive brain sites for suppression of ethanol intake and preference Critical thoughts on current rodent models for evaluating potential treatments of alcohol addiction and withdrawal Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson's disease.Modulation of high alcohol drinking in the inbred Fawn-Hooded (FH/Wjd) rat strain: implications for treatment.Varenicline ameliorates ethanol-induced deficits in learning in C57BL/6 mice.Acamprosate in the treatment of alcohol dependence: clinical and economic considerations.What's in the pipeline for the treatment of Parkinson's disease?Genetically selected alcohol preferring rats to model human alcoholism.Rat animal models for screening medications to treat alcohol use disorders.Central orexin (hypocretin) 2 receptor antagonism reduces ethanol self-administration, but not cue-conditioned ethanol-seeking, in ethanol-preferring rats.The Nicotinic α6-Subunit Selective Antagonist bPiDI Reduces Alcohol Self-Administration in Alcohol-Preferring Rats.Orexin-1 receptor signalling in the prelimbic cortex and ventral tegmental area regulates cue-induced reinstatement of ethanol-seeking in iP rats.Schedule-induced alcohol drinking: non-selective effects of acamprosate and naltrexone.The glycine reuptake inhibitor Org24598 and acamprosate reduce ethanol intake in the rat; tolerance development to acamprosate but not to Org24598.

P2860

Q24671740-FB50F0F4-3C60-452C-8E71-81D1A7944926 Q26862199-6D419BBC-A93F-47ED-B542-3CF612529A52 Q27349215-F879DAB5-3B20-473B-8F13-D007A8651648 Q28296440-90B051B9-B677-4D29-A3D8-E10B50141EC3 Q28299533-BA261EEB-CE4C-4DA7-BECE-7F65F9C3D0AE Q30447847-EC50C06A-2F66-4FF5-BA75-64C062098C62 Q33685890-3E4E7EF6-4BA4-4CFE-A57A-0EAAC55E25F1 Q33828177-88793097-563D-431D-888F-0EF52BCDB572 Q33869698-376BE0F0-F60A-4E38-A659-46E5465A240F Q34451242-4A5A8412-F0F1-4BD9-917C-021CBC3A3DB8 Q34588671-E1EC9323-E53D-409E-BE2F-CF5A75ECC70B Q35395058-C1EEA9B3-182E-43F6-A06B-6411E4DD52CE Q35589974-5A035596-96EA-4D6C-AD27-C89B7DDAC616 Q36254618-F2AECFD8-11CF-4634-B455-6C72622CE3AA Q36589468-4C429734-C660-4C49-A77E-435724BFB6F3 Q36746829-CE332613-DCE5-4E8E-89F5-192C5B91EC90 Q36998827-61F8F778-839A-4236-9335-93A314BD9D68 Q37352050-83717F61-8F44-4A1D-A4E0-291BA95FBF2A Q37495449-53A242D9-062F-435B-9D76-278BAB4A9394 Q39142990-C65003BF-383F-4ED3-A4B5-B06696EBF847 Q44345900-65C0AA59-B467-4D44-9481-E25E700B1E4B Q47403081-6F05CBF2-8D29-44C7-A001-21EC55907EC3 Q48217405-2E4B826D-5493-42CC-BE92-728D6D1F0684 Q48444517-9BDC019F-D951-43AE-98BB-20563908A24B Q48874232-D96C5541-F2D4-4E10-8A55-A4A58ACC9FCB

P2860

The acute anti-craving effect of acamprosate in alcohol-preferring rats is associated with modulation of the mesolimbic dopamine system.

http://www.wikidata.org/entity/Q46658074

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

The acute anti-craving effect ...... he mesolimbic dopamine system.

@en

The acute anti-craving effect ...... he mesolimbic dopamine system.

@nl

type

label

The acute anti-craving effect ...... he mesolimbic dopamine system.

@en

The acute anti-craving effect ...... he mesolimbic dopamine system.

@nl

prefLabel

The acute anti-craving effect ...... he mesolimbic dopamine system.

@en

The acute anti-craving effect ...... he mesolimbic dopamine system.

@nl

P1433

Q46658074-28F86976-061F-4D1F-BE9A-84F73CCF7998

P1476

Q46658074-629B809F-9A2A-4D83-B878-876B3517BF28

P2093

Q46658074-45E92B4A-9BED-4834-99C6-178D011D9128

Q46658074-970BA244-FB88-4294-95C5-71B2F8AEB368

Q46658074-97AA351F-A660-4B07-9F21-B58F7284F50A

Q46658074-D045FEBF-7406-41D9-9603-AE8F16951C5C

Q46658074-D29E1209-505C-4E40-A550-42252164A051

P2860

Q46658074-015E8B6F-E219-44A8-A146-8C17723D2CB5

Q46658074-0969A5BF-53FD-4C35-8549-0ACB1CE5E033

Q46658074-0B40CE5E-DE85-4394-AD12-DF4722E70212

Q46658074-19B8AEDF-69E1-4AA7-85C7-2DD727F8D400

Q46658074-21F46082-E212-47EF-BFF1-C1FF926E44A5

Q46658074-2AED5E5D-0524-47FB-A80D-D575E353135B

Q46658074-320F335D-C86B-42C2-8F0C-5D7FD6D7F377

Q46658074-345C56E2-93C1-44FB-95DE-B500756EE7B8

Q46658074-35375063-DBC2-4EED-A883-3FAB0E1D7ADC

Q46658074-394C55B9-40B0-4FD7-9EB7-521A069FA389

P304

Q46658074-7AF3750B-500F-414C-9D50-83F2BA7E6462

P31

Q46658074-01ECED4E-3147-46DA-A238-24DBE51EF686

P356

Q46658074-7F427E28-DA3D-46C2-ADAB-33A6574EB70A

P433

Q46658074-ADEB6103-D8D2-482B-9305-902FABAE74BB

P478

Q46658074-FD0FE720-4D41-4766-BC38-DC1ACC189427

P577

Q46658074-C17E30D6-8EB7-4207-9D5D-AEDEC0B4E93B

P5875

Q46658074-EB193C97-BDEC-489B-860E-8C1B8619CB58

P698

Q46658074-F384E6ED-42CB-4121-9C8C-F03B38E31E88

P921

Q46658074-5736832a-3e23-4787-b272-b4baa2328a16

P356

13556210500223132

P1433

Addiction Biology

P1476

The acute anti-craving effect ...... he mesolimbic dopamine system.

@en

P2093

Andrew J Lawrence

http://www.w3.org/2001/XMLSchema#string

Cameron Adams

http://www.w3.org/2001/XMLSchema#string

Michael S Cowen

http://www.w3.org/2001/XMLSchema#string

Tracey Kraehenbuehl

http://www.w3.org/2001/XMLSchema#string

Valentina Vengeliene

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical pharmacokinetics of acamprosate

The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption

Pharmacotherapy of alcohol dependence: a review of the clinical data.

Modulation of the neuronal dopamine transporter activity by the metabotropic glutamate receptor mGluR5 in rat striatal synaptosomes through phosphorylation mediated processes.

The dopamine hypothesis of reward: past and current status.

Effects of acute acamprosate and homotaurine on ethanol intake and ethanol-stimulated mesolimbic dopamine release.

Acamprosate enhances N-methyl-D-apartate receptor-mediated neurotransmission but inhibits presynaptic GABA(B) receptors in nucleus accumbens neurons.

The anti-relapse compound acamprosate inhibits the development of a conditioned place preference to ethanol and cocaine but not morphine.

Cyamemazine decreases ethanol intake in rats and convulsions during ethanol withdrawal syndrome in mice.

Oral ethanol self-administration in rats: models of alcohol-seeking behavior.

P304

233-242

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13556210500223132

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7650359

http://www.w3.org/2001/XMLSchema#string

P698

16109584

http://www.w3.org/2001/XMLSchema#string

P921